Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: XOY1YA7RMC

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Interferon alpha inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Lupus Erythematosus, Systemic 2 D008180 ClinicalTrials
Psoriasis 1 D011565 ClinicalTrials
Dermatomyositis 1 D003882 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 1006877-41-3
ChEMBL CHEMBL1743069
FDA SRS XOY1YA7RMC
Guide to Pharmacology 8257